Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China
- PMID: 39283023
- PMCID: PMC11406609
- DOI: 10.1177/03000605241274584
Performance evaluation of noninvasive prenatal testing on 24 chromosomes in a cohort of 118,969 pregnant women in Sichuan, China
Abstract
Objective: This study aimed to comprehensively analyze the detection capacity of non-invasive prenatal testing (NIPT) for chromosomal abnormalities of all 24 chromosomes, as well as high-risk indications for pregnancy and the fetal fraction, in a large cohort.
Methods: We retrospectively enrolled 118,969 pregnant women who underwent NIPT at Sichuan Provincial Maternity and Child Health Care Hospital from March 2019 to June 2022. The sensitivity, specificity, positive predictive value, negative predictive value, and positive chromosomal abnormality rate were calculated. The fetal fraction based on gestational age, maternal body mass index, and number was examined.
Results: NIPT demonstrated > 99% sensitivity and specificity for almost all of the common trisomies (T21, T18, and T13), sex chromosomal aneuploidies, rare autosomal trisomies, and microdeletion/microduplication syndromes. Positive predictive values varied from 12.0% to 89.6%. Advanced maternal age was associated with an increased risk of three major aneuploidies. The fetal fraction was positively correlated with gestational age and negatively correlated with the maternal body mass index.
Conclusions: NIPT can be used to effectively screen for chromosomal abnormalities across all 24 chromosomes. Advanced maternal age is a risk factor for high-risk pregnancy, and careful consideration of the fetal fraction is essential during NIPT.
Keywords: Noninvasive prenatal testing; aneuploidy; fetal fraction; prenatal screening; sensitivity; specificity.
Conflict of interest statement
Declaration of conflicting interestThe authors declare that there is no conflict of interest.
Figures



Similar articles
-
Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China.J Assist Reprod Genet. 2020 Dec;37(12):3143-3150. doi: 10.1007/s10815-020-01977-2. Epub 2020 Oct 23. J Assist Reprod Genet. 2020. PMID: 33094428 Free PMC article.
-
Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.Ultrasound Obstet Gynecol. 2020 Feb;55(2):242-247. doi: 10.1002/uog.20416. Epub 2020 Jan 8. Ultrasound Obstet Gynecol. 2020. PMID: 31364782
-
Cell-free fetal DNA testing and its correlation with prenatal indications.BMC Pregnancy Childbirth. 2021 Aug 24;21(1):585. doi: 10.1186/s12884-021-04044-5. BMC Pregnancy Childbirth. 2021. PMID: 34429082 Free PMC article.
-
Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.Ultrasound Obstet Gynecol. 2014 Mar;43(3):254-64. doi: 10.1002/uog.13277. Epub 2014 Feb 10. Ultrasound Obstet Gynecol. 2014. PMID: 24339153 Review.
-
Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.Arch Gynecol Obstet. 2023 Sep;308(3):787-795. doi: 10.1007/s00404-022-06908-3. Epub 2023 Jan 5. Arch Gynecol Obstet. 2023. PMID: 36602559 Review.
Cited by
-
Internet-Based Abnormal Chromosomal Diagnosis During Pregnancy Using a Noninvasive Innovative Approach to Detecting Chromosomal Abnormalities in the Fetus: Scoping Review.JMIR Bioinform Biotechnol. 2024 Oct 16;5:e58439. doi: 10.2196/58439. JMIR Bioinform Biotechnol. 2024. PMID: 39412876 Free PMC article.
References
-
- Xu H, Wang S, Ma LL, et al.. Informative priors on fetal fraction increase power of the noninvasive prenatal screen. Genet Med 2018; 20: 817–824. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources